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Abstract: We examined intensity and shape differences  in 378 repeated 
spectroscopic measures of the cervix. We examined causes of variability 
such as presence of precancer or cancer, pathologic tissue type, menopausal 
status, hormone or oral contraceptive use, and age; as well as technology 
related variables like generation of device and provider making exam. Age, 
device  generation,  and  provider  were  statistically  significantly  related  to 
intensity differences. Provider and device generation were related to shape 
differences. We examined the order of measurements and found a decreased 
intensity in the second measurement due to hemoglobin absorption. 96% of 
repeat  measurements  had  classification  concordance  of  cervical 
intraepithelial neoplasia. 
©2010 Optical Society of America 
OCIS codes: (120.0120) Instrumentation, measurement, and metrology; (170.0170) Medical 
optics and biotechnology; (300.0300) Spectroscopy. 
References and links 
1.  J. Freeberg, D. Serachitopol, N. McKinnon, R. Price, E. N. Atkinson, D. D. Cox, C. MacAulay, R. Richards-
Kortum, M. Follen, and B. Pikkula, “Fluorescence and reflectance device variability throughout the progression 
of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe,” J. Biomed. Opt. 
12(3), 034015 (2007). 
2.  N. Marín, N. MacKinnon, C. MacAulay, S. K. Chang, E. N. Atkinson, D. D. Cox, D. Serachitopol, B. Pikkula, 
M. Follen, and R. Richards-Kortum, “Calibration standards for multicenter clinical trials of fluorescence 
spectroscopy for in vivo diagnosis,” J. Biomed. Opt. 11(1), 014010 (2006). 
3. S.B. Cantor, J.M. Yamal, M. Guillaud, D.D. Cox, E.N. Atkinson, J.L. Benedet, D. Miller, T. Ehlen, J. Matisic, D. 
van Niekerk, M. Bertrand, A. Milbourne, H. Rhodes, A. Malpica, G. Staerkel, S. Nader-Eftekhari, K. Adler-
Storthz, M.E. Scheurer, K. Basen-Engquist, E. Shinn, L.A. West, A.T. Vlastos, X. Tao, J.R. Beck, C. MacAulay, 
and M. Follen, “Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: testing a 
device as an adjunct to colposcopy,” Int. J. Cancer (accepted for resubmission). 
4.  S. K. Chang, M. Dawood, G. Staerkel, U. Utzinger, E. N. Atkinson, R. Richards-Kortum, and M. Follen, 
“Fluorescence spectroscopy for cervical precancer detection: Is there variance across the menstrual cycle?” J. 
Biomed. Opt. 7(4), 595–602 (2002). 
5.  D. D. Cox, S. K. Chang, M. Dawood, G. Staerkel, U. Utzinger, R. Richards-Kortum, and M. Follen, “Detecting 
the signal of the menstrual cycle in fluorescence spectroscopy of the cervix,” Appl. Spectrosc. 57(1), 67–72 
(2003). 
6.  A. Nath, K. Rivoire, S. Chang, D. Cox, E. N. Atkinson, M. Follen, and R. Richards-Kortum, “Effect of probe 
pressure on cervical fluorescence spectroscopy measurements,” J. Biomed. Opt. 9(3), 523–533 (2004). 
#129414 - $15.00 USD Received 2 Jun 2010; revised 5 Aug 2010; accepted 17 Aug 2010; published 19 Aug 2010
(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  6417.  K. Rivoire, A. Nath, D. D. Cox, E. N. Atkinson, R. Richards-Kortum, and M. Follen, “The effects of repeated 
spectroscopic pressure measurements on fluorescence intensity in the cervix,” Am. J. Obstet. Gynecol. 191(5), 
1606–1617 (2004). 
8.  C. Brookner, U. Utzinger, M. Follen, R. Richards-Kortum, D. D. Cox, and E. N. Atkinson, “Effects of 
biographical variables on cervical fluorescence emission spectra,” J. Biomed. Opt. 8(3), 479–483 (2003). 
9.  C. Brookner, M. Follen, I. Boiko, J. Galvan, S. Thomsen, A. Malpica, S. Suzuki, R. Lotan, and R. Richards-
Kortum, “Autofluorescence patterns in short-term cultures of normal cervical tissue,” Photochem. Photobiol. 
71(6), 730–736 (2000). 
10.  N. Ramanujam, R. Richards-Kortum, S. Thomsen, A. Mahadevan-Jansen, M. Follen, and B. Chance, “Low 
Temperature Fluorescence Imaging of Freeze-trapped Human Cervical Tissues,” Opt. Express 8(6), 335–343 
(2001). 
11.  R. Drezek, C. Brookner, I. Pavlova, I. Boiko, A. Malpica, R. Lotan, M. Follen, and R. Richards-Kortum, 
“Autofluorescence microscopy of fresh cervical-tissue sections reveals alterations in tissue biochmistry with 
dysplasia,” Photochem. Photobiol. 73(6), 636–641 (2001). 
12.  R. Drezek, K. Sokolov, U. Utzinger, I. Boiko, A. Malpica, M. Follen, and R. Richards-Kortum, “Understanding 
the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and 
implication,” J. Biomed. Opt. 6(4), 385–396 (2001). 
13.  R. Drezek, M. Guillaud, T. Collier, I. Boiko, A. Malpica, C. Macaulay, M. Follen, and R. Richards-Kortum, 
“Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA 
content, and chromatin texture,” J. Biomed. Opt. 8(1), 7–16 (2003). 
14.  D. Arifler, I. Pavlova, A. Gillenwater, and R. Richards-Kortum, “Light scattering from collagen fiber networks: 
micro-optical properties of normal and neoplastic stroma,” Biophys. J. 92(9), 3260–3274 (2007). 
15.  I. Pavlova, K. Sokolov, R. Drezek, A. Malpica, M. Follen, and R. Richards-Kortum, “Microanatomical and 
biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence 
confocal microscopy,” Photochem. Photobiol. 77(5), 550–555 (2003). 
16.  J. S. Lee, O. Shuhatovich, R. Price, B. Pikkula, M. Follen, N. McKinnon, C. Macaulay, B. Knight, R. Richards-
Kortum, and D. D. Cox, “Design and preliminary analysis of a study to assess intra-device and inter-device 
variability of fluorescence spectroscopy instruments for detecting cervical neoplasia,” Gynecol. Oncol. 99(3), 
S98–S111 (2005). 
17.  B. M. Pikkula, O. Shuhatovich, R. L. Price, D. M. Serachitopol, M. Follen, N. McKinnon, C. MacAulay, R. 
Richards-Kortum, J. S. Lee, E. N. Atkinson, and D. D. Cox, “Instrumentation as a source of variability in the 
application of fluorescence spectroscopic devices for detecting cervical neoplasia,” J. Biomed. Opt. 12(3), 
034014 (2007). 
18.  B. Pikkula, D. Serachitopol, C. MacAulay, N. Mackinnon, J. S. Lee, D. D. Cox, E. N. Atkinson, M. Follen, and 
R. Richards-Kortum, “Multicenter clinical trials of in vivo fluorescence: are the measurements equivalent?” Proc 
SPIE 6430–64301Q (2007). 
19.  D. M. Gershensen, A. H. DeCherney, S. L. Curry, and L. Brubaker, Operative Gynecology, 2nd edition, 
(Saunders, 2001). 
20.  H. Zhu, and D. D. Cox, “A Functional Generalized Linear Model with Curve Selection in Cervical Pre-cancer 
Diagnosis Using Fluorescence Spectroscopy,” Optimality: The Third Erich L. Lehmann Symposium 57, 173–
189 (2009). 
21.  H. Zhu, M. Vannucci, and D. D. Cox, “A Bayesian Hierarchical Model for Classification with Selection of 
Functional Predictors,” Biometrics 66(2), 463–473 (2010). 
1. Introduction 
The  spectroscopic  device  that  we  analyze  here  is  a  candidate  technology  for  automated 
detection of cervical cancer  and could be used in a clinic to replace biopsies and permit 
diagnosis and treatment in a single visit. 
Studies confirm that optical technologies can potentially provide a real-time diagnosis of 
tissue condition based on the molecular and morphologic changes associated with precancer. 
Inexpensive, small and portable optical sensors coupled with software for automated signal 
analysis could potentially yield an objective and reproducible diagnosis in the hands of the 
non-expert. Thus, the potential of optical technologies is enormous. 
Many factors exist that possibly increase the measurement error including the coupling of 
the probe and tissue, environmental factors, and movement of the probe or of the tissue during 
the  measurement  process.  The  variability  in  the  measurements  can  directly  impact  the 
classification  accuracy  of  the  device.  It  is  therefore  desirable  to  quantify  the  amount  of 
variability and seek to identify ways to minimize this. 
Although there have been many studies using optical spectroscopy, there is relatively little 
investigation into the variability within a patient and the biological and environmental factors 
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taken  at  the  same  location  of  the  cervix  in  the  same  patient  and  to  identify  factors  that 
contribute to this variability. We then propose ways to minimize this variability in future 
studies. 
2. Methods 
Overview of Study Procedures 
Details of the research grade, fiber-optic spectrometers used during the trial can be found in 
Freeberg  et  al.  [1].  The  devices  measured  fluorescence  emission  spectra  at  16  different 
excitation wavelengths ranging from 330 nm to 480 nm and collected at a range of emission 
wavelengths between 360 nm to 800 nm. These data are referred to as an excitation-emission 
matrix (EEM). There were two generations of the device used during the seven years of the 
trial. The second-generation device improved over the first generation in that it was cheaper to 
construct and took less time to make measurements. The details of the processing of the data 
from these devices can be found in Marin, et al. [2]. 
Details of the study procedures can be found in Cantor, et al. [3]. Following colposcopic 
examination, a fiber optic probe 5.1 mm in diameter (2mm optically active center window) 
was  advanced  through  the  speculum  and  placed  in  gentle  contact  with  the  cervix. 
Spectroscopic measurements were obtained from one or two colposcopically normal cervical 
sites  covered  with  squamous  epithelium  and,  when  visible,  one  colposcopically  normal 
cervical  site  with  columnar  epithelium.  If  abnormalities  were  present  and  visible, 
measurements were taken from one or more colposcopically-abnormal sites. Thus, all patients 
had sampling of both abnormal and normal areas, if colposcopic abnormalities were present. 
Following spectroscopic measurements, all sites interrogated with the fiber optic probe were 
biopsied with a biopsy forceps yielding specimens that were 2 mm long by 1 mm wide by 1 
mm deep, approximately the same volume interrogated by the probe. The histopathologic 
consensus diagnosis among pathologists was used as the gold standard for the trial. 
Ten percent of all spectra, throughout the duration of the study, were explicitly repeated 
for purposes of investigating the variability from measurement to measurement. The probe 
left a 2mm circular impression on the cervix. The center of the probe has both the light-
emitting  and  light-detection  systems.  The  repeat  measurement  was  registered  to  the  first 
measurement by using the impression to direct the placement of the probe, approximately 30-
60 seconds after the first measurement. The biopsy device was then used in the center of the 
circular impression so that the biopsy site was as close as possible to the spectroscopic site. 
After removing any pairs where at least one measurement did not pass quality assurance, we 
were left with 378 sites with repeat measurements (267 unique patients). 158 patients had 
repeat measurements at one site, 107 had repeat measurements at two sites, and two patients 
had repeat measurements at three sites. 
Previous experiments examining the importance of the day of the menstrual cycle showed 
only that blood from menstruation affected measurement; thus, similarly to clinical practice, 
patients  were  rescheduled  if  menstruating  [4,5].  Similarly,  experiments  examining  probe 
pressure were conducted and showed no statistically significant effect from different degrees 
of pressure over a range of values that approximated those used by providers [6,7]. 
We  were  interested  in  seeing  the  possible  effect  of  several  factors  on  the  variability 
between pairs of measurements at the same site. Factors that we believe might cause changes 
to  the  vasculature  in  the  cervix  and  therefore  cause  variability  in  the  spectroscopic 
measurements  include  1)  the  severity  of  disease  measured  by  the  histologic  grade  of  the 
biopsy into the three categories normal, low-grade squamous intraepithelial lesion (SIL), and 
high-grade SIL or cancer, 2) age, 3) colposcopic tissue type, using five categories ranging 
from squamous to columnar tissue, 4) menopausal status (pre-, peri-, or post-menopausal), 
and  5)  oral  contraceptive  use  [8–15].  Two  additional  factors  that  are  technology  related 
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provider made the measurements (eight providers) [16–18]. 
Statistical Methods 
Our aim is to characterize the similarity between the repeat measurements, and if they are not 
similar, then to determine if the differences are more in shape or intensity (or both). Let  ijk y = 
measurement for site i, with j denoting the order of the measurement (first or second), and k 
labeling the excitation-emission wavelength pair. We will denote the vector of all intensities 
for patient i and measurement j by ij y • . We define a relative measure of the squared distance 
between the two spectra: 
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intensity  difference.  Note  that 0 i I ≥   and 0 i I =   if  and  only  if 
2 2
1 2 i i y y • • = .  Also,  if 
1 2 / i i y y • • → ∞  or  0 →  then i I → ∞  so the intensity difference depends on the ratio of the 
intensities and not strictly speaking on the differences. The second term in the expansion 
for
2
i d , namely  2(1 ) i i s r = −  can be thought of as a measure of the difference in shapes. Note 
that  i r  is similar to a correlation between the two EEMs. If the two EEMs have the same 
shape (i.e., one is a positive multiple of the other), then 0 i s = . It takes its largest value  2 i s =  
if all excitation-emission wavelength pairs where one EEM is positive occur only where the 
other is 0. A higher value for either difference measure indicates a larger difference. 
A linear mixed-effects model was used to compare the effect of covariates on the log of 
the difference measures. The  10 log  transformation was applied to the intensity and shape 
differences in order to satisfy the normality assumption in the model. The variables histologic 
grade, device generation (first or second generation), age, menopause status, provider, oral 
contraceptive use, and histologic tissue type (with five levels) were selected as predictors 
(although the device generation and provider identification were confounded). We included 
the variables that were previously found to be important for classification and included others, 
based on clinical judgement, that had the potential of affecting how the tissue responded to 
the probe pressure (or some other perturbation of the tissue due to the first measurement) and 
therefore affect the second measurement. For example, the histologic grade was chosen since 
there is increased neovasculature (and increased blood flow) with neoplasia. The increased 
blood flow in the area of measurement can increase variability of repeated measurements. 
Similarly, as tissue ages, there are changes in the elastin and collagen, leading to firmer tissue 
and less vessels present. Generally, with increased estrogenization, there is more blood flow 
(menopause status and oral contraceptive use). The histologic tissue type was chosen since 
there is entirely different vasculature in each tissue type. 
The patient identifier was modeled as a random effect and restricted maximum likelihood 
was used to fit the model. The linear mixed-effects model can be represented as 
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where  m β  and  mpi x , m = 1,…,7, represent the coefficients and variables of the predictors 
histologic grade, device generation, age, menopause status, provider, oral contraceptive use, 
and  histologic  tissue  type  for  patient  p  and  site  i.  The  coefficient  b   and  variable  p z  
correspond to the random effect of the patient identification, with 
2 ~ (0, ) p b N σ . This model 
produces a covariance matrix with compound symmetry structure. The same model was used 
for the shape difference measure. 
Our second objective is to detect if there is an increase or decrease in intensities between 
the first and second measurements taken. Let  2 1 ik i k i k y y δ = −  denote the difference between 
the first and second repeat measurements for patient i and excitation-emission pair k. We will 
denote  k δ• as  the  vector  of  differences  ik i δ ∀   and  k δ •   as  the  mean  of  the  vector . k δ• We 
calculated a z score defined by 
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taking the difference of the means of the excitation-emission pair across all N pairs of EEMs 
and dividing by the standard error of the difference of each pair for that excitation-emission 
pair. The z-score is a dimensionless standardized score that  gives information about  how 
many standard deviations an observation is above or below the mean. 
To  determine  which  excitation-emission  pairs  had  the  most  variability  between  repeat 
measurements, we computed a measure of the variance for every excitation-emission pair. For 
every  excitation-emission  pair  k,  we  computed  the  standard  deviation  of  the  difference 
between the two repeated measures among all EEMs, 
2 1/2
1
1
[ ( ) ]
1
N
k ik
i N
δ δ •
=
−
− ∑ . This was then 
standardized by dividing by the mean intensity for that excitation-emission pair. 
Statistical  analysis  was  performed  using  the  statistical  packages  R  version  2.6.2  (R 
Foundation for Statistical Computing, Vienna, Austria) and JMP version 7.0.1 (SAS Institute, 
Cary, North Carolina, USA). Confidence intervals for proportions were calculated using the 
exact binomial test. 
3. Results 
We had repeat measurement data on 378 sites. The distributions of the covariates are shown 
in Tables 1–7. 
Table 1. Table of the distribution of the histologic grade of the biopsies 
Histologic grade of biopsy 
normal 
201 
Low-grade SIL 
116 
High-grade SIL or cancer 
61 
Table 2. Table of the age distribution 
Age 
minimum  1st quartile  median  mean  3rd quartile  Max 
18  28  36  38.05  47  70 
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range from ecto-cervical to endo-cervical, coded numerically as one to five 
Pathology tissue type 
Ecto-cervical  Primarily ecto-
cervical 
Both endo- and 
ecto-cervical 
Primarily endo-
cervical 
Endo-cervical 
177  36  109  16  40 
Table 4. Table of the distribution of the menopausal status 
Menopausal status 
Pre-menopausal  Peri-menopausal  Post-menopausal 
295  19  64 
Table 5. Table of the distribution of the generation of the device used to obtain the 
spectroscopic measurements 
Device generation 
1st 
generation 
2nd generation 
204  174 
Table 6. Table of the distribution of the provider obtaining the measurements 
Provider 
1st  2nd  3rd  4th  5th  6th  7th  8th 
39  64  113  11  36  14  37  64 
Table 7. Table of the distribution of the oral contraceptive use 
Oral contraceptive use or HRT use 
No  Yes 
283  95 
We computed the overall difference for the 378 sites that had a repeated measurement. 
The overall difference measure is right-skewed, with most of the points close to 0. The  10 log  
transformation is approximately normally distributed (Fig 1). The median overall difference 
of 
2
i d  is 0.12, a median of  0.12  = 35% difference between the repeat measurements. The 
range of the 
2
i d  values was 0.0005 to 16.8 (1st quartile 0.003, 3rd quartile 0.32). 
We present separate analyses for the intensity and shape differences. 
 
Fig. 1. Histogram of the overall  10 log  difference between repeat EEMs showing a median of 
35% difference. 
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The intensity difference component of the overall difference measure had a median of 0.08. 
Some examples of the lowest, median, and highest intensity differences are shown in Fig. 2. 
Each plot is a pair of measured EEMs taken at the same site of a patient. Each EEM matrix 
has  been  concatenated  into  a  single  vector,  by  excitation  wavelength,  for  all  excitation-
emission pairs – the resulting plotted line has 16 modes for the 16 excitation wavelengths. 
The  measurement  pairs  with  the  highest  intensity  difference  identified  pairs  where  one 
measurement possibly should not have passed quality control. The median values identified 
pairs that had a moderate intensity difference at some excitation wavelengths. 
 
Fig. 2. Examples of repeat EEMs that have the lowest intensity difference (first row), median 
intensity differences (second row), and highest intensity difference between them (third row). 
The black (solid) and red (dotted) lines denote the first and second EEMs at the same barcode 
and clock position, respectively. Each EEM matrix was concatenated (by the 16 excitation 
wavelengths) to form a vector of excitation-emission pairs. 
Linear mixed-effects model results for intensity difference 
The  variables  device  generation  and  provider  identification  were  confounded;  hence,  the 
linear  mixed-effects  model  failed  to  converge.  When  the  device  generation  variable  was 
removed  from  the  model,  both  patient  age  and  provider  identification  were  statistically 
significant in the linear mixed-effects model (p = 0.047 and p = 0.023, respectively). When 
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significant (p = 0.057) and device generation was highly statistically significant (p = 0.001). 
Figures 3–5 show plots of intensity difference versus these statistically significant factors. 
 
Fig. 3. Scatter plot of  10 log  of intensity difference between repeats of EEMs versus age. This 
shows an increase in the intensity difference for older women. 
A  regression  line  is  drawn  on  the  scatterplot,  showing  a  slight  upward  trend  in  the 
intensity difference as age increases. 
 
Fig. 4. Device generation versus  10 log  intensity difference between repeats of EEMs. 
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Fig. 5. Boxplots of  10 log  (intensity difference) by provider. 
Shape difference 
The shape measure is plotted for the two EEM pairs with the lowest values, median values, 
and  with  the  highest  values  (Fig.  6).  To  aid  the  visual  comparison  in  these  graphs,  we 
normalized shape log intensities by dividing by the square root of the sum of squares for that 
observation. The black (solid) and red (dotted) lines are the concatenated vector of 
1
1
i
i
y
y
•
•
 and 
2
2
i
i
y
y
•
•
, respectively. 
Linear mixed-effects model results for shape difference 
Again, variables device generation and provider identification were confounded. We fit the 
model omitting each variable one at a time. When the provider variable was omitted, the 
device generation variable was statistically significant (p = 0.0002, Fig. 7). When the device 
generation  variable  was  omitted,  the  provider  identification  variable  was  statistically 
significant (p<0.0001, Fig. 8). There is more of a shape difference for the second-generation 
device than the first generation. There is more of a shape difference for providers 3, 4, and 8. 
There does not appear to be any association with the number of measurements each provider 
obtained (Table 6). 
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Fig. 6. Examples of repeat EEMs which have the lowest (top row), median (middle row), and 
highest (bottom row) shape difference between them. The black (solid) and red (dotted) lines 
denote the first and second EEMs at the same barcode and clock position, respectively. Each 
EEM  matrix  was  concatenated  (by  the  16  excitation  wavelengths)  to  form  a  vector  of 
excitation-emission pairs. A low shape difference value denotes two EEMs that have similar 
shape. 
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Fig. 7. Boxplots of  10 log  shape difference by device generation. There is more of a shape 
difference for pairs of EEMs in the 2nd generation device. 
 
Fig. 8. Boxplots of  10 log  (shape difference) by provider. 
Effect of the order the measurements were taken 
The process of obtaining a  measurement can cause temporary changes in the tissue. Our 
conjecture was that a second reading done right after the first might be influenced by possible 
after-effects on the tissue from having just had the probe pressed against the tissue or the 
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of the difference between the first and second measurements contained no outliers, yet were 
overwhelmingly negative (range from −1.92 to 0.08). Figure 9 shows a heat map and contours 
of the EEM z values. 
Since we found statistically significant differences between the two generations of device, 
we stratified the analysis separately by each generation of device. 
 
Fig. 9. Plot of z values for 2nd measurement - 1st measurement. 
The mean of the z values decreased from the first to the second measurement. 
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Fig. 10. Plot of z values for (2nd measurement - 1st measurement) by device generation. 
We observed a difference between the first and second generation devices (Fig. 12). The 
second generation device tended to have a smaller difference between the first and second 
measurements, yet the differences were mostly negative indicating a decrease in intensity for 
the second measurement. The majority of the first generation device z values were negative – 
most EEM pairs z values decreased in the second measurements except for regions with high 
excitation and emission values. 
Excitation-Emission Pairs having the most amount of variation 
Figure 11, an EEM plot of the standard deviation between the first and second measurements, 
shows that the greatest standard deviation is around excitation 410, and emission 460. The 
standard deviation is not constant throughout the EEM but increases around the area where 
hemoglobin absorption plays a role in the intensities. 
#129414 - $15.00 USD Received 2 Jun 2010; revised 5 Aug 2010; accepted 17 Aug 2010; published 19 Aug 2010
(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  653 
Fig. 11. EEM plot of the normalized standard deviation between the 1st and 2nd 
measurements. 
Repeatability and concordance 
To  further  assess  how  repeatability  affected  classification,  we  examined  the  classification 
concordance of the repeat measurements given the classification algorithm developed in [3]. 
We calculated the percentage of repeat measures that were classified into different classes 
(low-grade  SIL  or  better  versus  high-grade  SIL  or  cancer)  than  its  repeat  measurement. 
Overall, 4% of the repeat measurements were not concordant. The same was done for repeat 
pairs in each quartile of the intensity difference measure and the shape difference measure. 
The  barplots  for  intensity  difference  and  shape  difference  are  shown  in  Figs.  12  and  13, 
respectively.  There  is  no  obvious  trend  between  the  percentage  of  concordance  and  the 
quartiles of the difference measures. 
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Fig.  12.  Barplot  of  percentage  of  repeat  measurements  whose  classification  class  was  not 
concordant by intensity difference. The error bar gives the 95% confidence interval. 
 
Fig.  13.  Barplot  of  percentage  of  repeat  measurements  whose  classification  class  was  not 
concordant by shape difference. The error bar gives the 95% confidence interval. 
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Several factors influenced the repeatability of the EEMs. Measurements taken at the same 
location of the same patient should look identical yet many have substantial intensity and 
shape differences between them. The generation of device, age, and provider identification are 
associated with the degree of intensity difference. The generation of device and provider are 
associated with the shape differences. 
We observed more differences for the second generation device than in the first generation 
device.  All  first  generation  device  measurements  were  taken  in  Houston  and  all  second 
generation device measurements were taken in Vancouver, causing confounding of what the 
source of the observed differences is. The difference could include engineering differences 
between the two generations of devices and differences between providers or test conditions. 
The second generation device had the advantage of being able to obtain measurements more 
quickly and the device itself was less expensive to construct. However, each generation of 
device  has  a  different  way  of  resetting  the  filter  wheels  before  acquiring  another 
measurement. We will examine the possible filter wheel effect in a forthcoming manuscript. 
Providers 3-6 were in Vancouver and the rest were in Houston. The Vancouver measurements 
were dominated by Provider 3, having the lion’s share of repeat measurements (n = 113) and 
the  highest  shape  difference  among  all  providers.  This  is  a  possible  explanation  for  the 
observed generation difference. 
Many additional factors could potentially explain the provider differences. Each provider 
used varying amounts of pressure when pressing the probe on the tissue and the imprint on the 
tissue  could  help  direct  the  placement  of  the  probe  in  the  same  location  for  the  second 
measurement. We are surprised by the provider effect because previous studies of pressure 
didn’t find any statistically significant differences between different pressure amounts. We are 
going to re-explore this issue in future studies. Steadiness of the hand might also influence the 
repeatability,  although  the  second  generation  device,  which  obtained  measurements  faster 
than the first, exhibited more variation. We thought that having to hold the probe to the tissue 
for less time would result in more repeatable measurements. Interestingly, we don’t think that 
experience influenced the provider differences. The providers that had the largest difference 
between  their  first  and  second  measurements  had  widely  varying  levels  of  experience 
obtaining spectroscopic measurements in our study. 
As women age, there is less estrogen in cervical tissue and this leads to atrophy. The 
atrophic cervix is often firmer than the well-estrogenized cervix of younger women [19]. We 
have not yet sorted out what changes are due to age and what are due to decreased estrogen. 
We hypothesize that  the  increase in intensity difference is due to  gradual changes in the 
epithelium  as  the  woman  becomes  postmenopausal.  There  was  a  slightly  larger  intensity 
difference for postmenopausal women on hormone replacement therapy than postmenopausal 
women not on hormone replacement therapy (p = 0.08). 
We observed a decrease in EEM intensities from the first to the second measurements. We 
hypothesize that this is due to increased hemoglobin absorption (Figs. 9 and 10). We note 
more of a difference in the areas of the EEM matrix where blood is absorbed, mainly around 
excitation wavelengths 420-430 and separately at the band at emission wavelengths 400-450 
nm.  We  believe  that  the  compression  of  the  tissue  from  the  first  measurement  leads  to 
revascularization  of  the  tissue,  causing  more  hemoglobin  absorption  during  the  second 
measurement. In our study, the second measurement was taken 30-60 seconds after the first, 
which  may  have  caused  increased  hemoglobin  absorption  in  the  second  measurement. 
Systematic differences between the first and second measurement are hypothesized to be an 
artifact of making an additional measurement rather than of the repeatability of the device. 
Classification  algorithms  that  either  use  only  one  measurement  at  the  same  site  or  use 
excitation-emission pairs that are invariant to hemoglobin absorption would not be affected by 
this artifact. 
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460.  Interestingly,  Zhu  demonstrated  that  the  most  important  excitation  wavelengths  for 
classification using these devices are, in order, 340 nm, 460 nm, 420 nm, and 410 nm [20]. 
The two most important wavelengths have a low amount of variability. In another anlaysis, 
the two most important excitation wavelengths are 360 nm and 400 nm [21]. The second most 
important wavelength has a high degree of variability although it still retained classification 
concordance. 
Classification  algorithms  depend  on  clean,  reproducible  data  to  be  able  to  accurately 
predict independent data. The degree of repeatability of new devices can be a major source of 
variation. If the device variation exists in areas of the variable space that is being used by a 
classifier, this decrease in repeatability can adversely affect the accuracy to detect disease. We 
found  that  the  top  wavelengths  that  have  been  used  in  classifiers  have  a  relatively  low 
variance between repeat measurements – however, many excitation wavelengths with high 
variance have also been found to be predictive of disease. Minimizing variance by controlling 
factors that might introduce additional variability might help increase the predictive accuracy 
of classification algorithms. 
Although we observed a 35% overall median difference between the repeat measurements, 
only  4%  were  classified  into  different  classes  than  their  repeat  pair  by  the  classification 
algorithm.  Several  factors  influenced  the  repeatability.  However,  the  high  concordance 
suggests high utility/repeatability of spectroscopy for the classification of cervical neoplasia. 
The contribution of this manuscript is twofold. First, it proposes methodology to assess the 
repeatability of spectroscopic data, with respect to covariates. We are not aware of other work 
that uses a similar approach to characterize shape and intensity differences of functional data. 
Second,  repeatability  studies  of  emerging  technologies,  incorporating  patient  covariate 
information, are extremely  important in the transition  from a research device to a  usable 
device. Emerging devices should be repeatable, especially for classification. If measuring at 
roughly the same location results in wildly varying measurements, it would have important 
implications about the utility of the device. Our clinical trial was designed with a repeatability 
study built-in, and we recommend this type of study design for emerging technologies. 
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